Actos Bladder Cancer Victim Files Lawsuit Against Takeda Pharmaceuticals
By Matt O’Donnell
A Minnesota resident has filed an Actos bladder cancer lawsuit against Takeda Pharmaceuticals for failure to warn of the diabetes drug’s deadly side effects. The man claims he developed bladder cancer a mere seven months after being prescribed Actos, and claims he never would have taken the drug to treat his type II diabetes if he knew the risks. His Actos attorney is seeking over $50,000 in damages from Takeda to help cover the man’s medical expenses, pain and suffering.Plaintiff George Geogleris alleges in the Actos lawsuit, filed May 25, 2012 in the Circuit Court of Cook County, Illinois, that he began taking Actos in February 2011 and stopped using it in September 2011. Geogleris claims the drug caused him to develop bladder cancer and undergo surgery to correct the problem. His Actos lawsuit wants Takeda Pharmaceuticals held liable for not warning patients and doctors about the risk of Actos bladder cancer, which his lawyer claims Takeda knew — or should have known — existed based on numerous adverse event reports and a June 2011 FDA warning that using Actos for more than one year increased the risk of bladder cancer by 40 percent.
Updated August 2nd, 2012
{loadposition content_postads}
All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.
Top Class Actions Legal Statement

